The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
NCT06871358
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
STEMI (STE-ACS)
Primary PCI for STEMI
Interventions
DRUG:
Atorvastatin 80mg
DRUG:
Placebo
Sponsor
Universitas Sebelas Maret